Q4 2009 13F Holders as of 31 Dec 2009
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
813,999
-
Share change
-
-115,870
-
Total reported value
-
$45,728,975
-
Price per share
-
$56.18
-
Number of holders
-
6
-
Value change
-
-$6,509,506
-
Number of sells
-
4
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q4 2009
As of 31 Dec 2009,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
813,999 shares.
The largest 6 holders included
HUNTINGTON NATIONAL BANK, Glenview Trust Co, Northwest & Ethical Investments L.P., Detwiler Fenton Investment Management LLC, HUNTINGTON ASSET ADVISORS, INC., and Rehmann Capital Advisory Group.
This page lists
6
institutional shareholders reporting positions in this security
for the Q4 2009 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.